Rayner Newsroom

Rayner is pleased to announce its direct entry into the Italian cataract market.

The entire Rayner IOL & injector portfolio, available in Italy for the last 20 years via independent distributors, is now available through Rayner Italia Srl.

"CRST Europe: What can you tell us about RayOne IOLs?

Mr. Clover: We are currently at the point of validation and regulatory approvals, and when we start manufacturing here, in a short time, it will be a wholly new product. It will be leapfrogging, we hope, to the front of the pack in terms of product innovation..."

If ever there were a year for Rayner to be earning solid media coverage, 2016 is certainly off to a flying start. And the company has a lot to talk about.

On this occasion, it was the Grand Opening of The Ridley Innovation Centre – a brand new, state of the art dedicated intraocular lens production facility – which was making headlines.

On Friday 8th April, Worthing presented a glorious Spring morning, and an enthusiastic group of surgeons, industry media and company stakeholders gathered in the reception of The Ridley Innovation Centre for what was to be a high-spirited, high energy event...

State-of-the-art new facility
Today we open The Ridley Innovation Centre, our new £20million R&D, training and production facility in Worthing, West Sussex. This state of the art, dedicated intraocular lens (IOL) production facility has the capability of manufacturing 3 million intraocular lenses each year. In addition, our new Enterprise Resource Planning (ERP) quality system enables us to trace every lens from source materials to a patient’s eye. Rayner is the only IOL manufacturer in the UK and our investment represents commitment to delivering competitive high quality technology from a well-trained UK manufacturing team.

Rayner is an independent British business and one of the world’s top manufacturers of intraocular lenses (IOLs) for the global market. Last year alone we produced more than 800,000 IOLs.

Part of our business philosophy from day one has been a focus on innovation to provide cataract surgeons with high-quality, functionally superior and simple solutions that provide excellent patient outcomes. Indeed, we were the first to introduce the intraocular lens in 1949. We also developed Sulcoflex, the ‘top up’ lens for secondary implantation. In addition, we have just launched the world’s first OVD containing sorbitol Free Radical Scavenging for enhanced corneal protection.

The Human Resource department at Rayner have been busy taking part in the 2016 Coastal STEMfest, a campaign which consisted of interactive demonstrations, workshops and roadshows so that local educational institutions could link with over 90 science, technology, engineering and mathematics (STEM) businesses to encourage local school children to pursue careers in the field of science and engineering.

Reflecting the needs of our global customer, Rayner is pleased to announce that the French and Spanish translations of the company website www.rayner.com are now live.

Rayner.com/fr and rayner.com/es include thorough product information covering Rayner’s extensive IOL and OVD portfolio...

Rayner, the pioneering manufacturer of intraocular lenses for cataract surgery, has been named as one of the country’s top 10 companies in achieving sustained growth in international turnover.

Accountancy and business advisory firm BDO LLP’s analysis of the mid-market (companies with turnover between £10m-300m) has shown that Rayner is one of Sussex’s success stories, reporting impressive profit growth during the last three years.

Open New Year Letter from CEO. The past year has been a transformative one for Rayner as we transition to a company exclusively focused on IOLs and cataract surgery. The disposal of our retail business and move to new purpose built headquarters and state of the art 3 million lens manufacturing site in Worthing, UK is testament to our commitment to quality and innovation for surgeons performing and patients undergoing cataract surgery worldwide...

Voluntary Recall January 2016. Since 1950 Rayner has been known for high levels of product quality, a record of which we are proud. Our own internal limits are often set in excess of those demanded by regulatory bodies; one such example is aluminium oxide (used for polishing IOLs) for which we set stringent internal limits even though none are specified by the relevant international ISO standards. Unfortunately, there is a possibility that certain products released to market since 11th November 2015 may contain levels of this compound that slightly exceed these self imposed limits. This potentially affects non-US products released during this period. We have taken steps to quarantine the vast majority of affected products but some 2,400 lenses were released to market across a small number of hospitals.